<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="261">
  <stage>Registered</stage>
  <submitdate>23/08/2005</submitdate>
  <approvaldate>26/08/2005</approvaldate>
  <actrnumber>ACTRN12605000219684</actrnumber>
  <trial_identification>
    <studytitle>A prospective randomised controlled trial comparing the effects of metformin with the 20 microgram ethinyl estradiol oral contraceptive pill on the hormonal and metabolic profiles in women with polycystic ovarian syndrome.</studytitle>
    <scientifictitle>A prospective randomised controlled trial comparing the effects of metformin with the 20 microgram ethinyl estradiol oral contraceptive pill on the hormonal and metabolic profiles in women with polycystic ovarian syndrome.</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Polycystic Ovary Syndrome</healthcondition>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Other metabolic and endocrine disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Intervention is metformin for 6 months.</interventions>
    <comparator>Control is the microgram oral contraceptive pill for 6 months.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Fasting insulin &amp; glucose</outcome>
      <timepoint>At baseline (week 0), 3 months, 6 months and 9 months (i.e. 3 months after stopping the intervention)</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Clinical (weight, BMI, WHR, and BP, menstrual cyclicity).</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Hormonal (serum levels of FSH, LH, T, DHEAS, and SHBG).</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Other metabolic (fasting lipids) and radiological (body composition on DEXA) and timing.</outcome>
      <timepoint>At 3, 6, and 9 months.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>1.  Obese (BMI &gt; 28kg/m2) or non-obese (BMI &lt; 28kg/m2) PCOS as defined above2.  Amenorrhea or oligo-amenorrhea3.  No contraindications to OCP a)  History of, or current, thrombophlebitis, thromboembolic disorders and conditions which predispose to such diseases including venous thromboembolism. b)  History of, or existing, cerebral vascular/ coronary artery disease c)  Known or suspected carcinoma of the breast or the endometrium or a history of these d)  Impaired liver function or active liver disease e)  Undiagnosed abnormal vaginal bleeding f)  Known or suspected pregnancy g)  Women older than 35yrs age with hypertension, diabetes, or who smoke 4.  No contraindications to metformin a)  hypersensitivity to metformin or other biguanides b)  diminished renal function c)  cardiovascular disease (e.g. coronary insufficiency, myocardial infarction) d)  severe hepatic dysfunction e)  pancreatitis f)  excessive alcohol intake g)  concomitant use of diuretics5.  No medications (including hormones) known to alter gonadal function, carbohydrate metabolism, or lipoprotein metabolism taken during the two months preceding the study6.  Each woman to give informed consent to participate in the study.</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>Not stated</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>1.  Diabetes mellitis2.  Wishing to conceive.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Central randomisation by phone</concealment>
    <sequence>computer generated randomization</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Factorial</assignment>
    <designfeatures />
    <endpoint>Safety</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/04/2001</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>36</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Michael Costello</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Royal Hospital for Wormen</fundingname>
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>Nil</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Michael Costello</name>
      <address>Royal Hospital for Women
Barker St
Randwick NSW 2035</address>
      <phone>+61 2 93826677</phone>
      <fax />
      <email>mfcostello@unsw.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Michael Costello</name>
      <address>Royal Hospital for Women
Barker St
Randwick NSW 2035</address>
      <phone>+61 2 93826677</phone>
      <fax />
      <email>mfcostello@unsw.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>